Cargando…
Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17
BACKGROUND: Health-related quality of life (HRQoL) has become a major endpoint to assess the clinical benefit of new therapeutic strategies in oncology clinical trials. Typically, HRQoL outcomes are analyzed using linear mixed models (LMMs). However, longitudinal analysis of HRQoL in the presence of...
Autores principales: | Cuer, B., Mollevi, C., Anota, A., Charton, E., Juzyna, B., Conroy, T., Touraine, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469318/ https://www.ncbi.nlm.nih.gov/pubmed/32883216 http://dx.doi.org/10.1186/s12874-020-01104-w |
Ejemplares similares
-
When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials
por: Touraine, Célia, et al.
Publicado: (2023) -
Development of a Clinical–Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial
por: Egea, Julie, et al.
Publicado: (2022) -
The prodigal son
por: Britten, Benjamin, 1913-1976
Publicado: (1990) -
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial
por: Lambert, Aurélien, et al.
Publicado: (2017) -
Cilia - the prodigal organelle
por: Beales, Phil, et al.
Publicado: (2012)